Matthew Plunkett - Jul 15, 2021 Form 3 Insider Report for Imago BioSciences, Inc. (IMGO)

Role: Chief Financial Officer
Signature: /s/ Matthew Plunkett
Stock symbol: IMGO
Transactions as of: Jul 15, 2021
Transactions value $: $0
Form type: 3
Date filed: 7/15/2021, 05:37 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	IMGO	Stock Option (Right to Buy)							Jul 15, 2021	Common Stock	314K	$4.20	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Option vests with respect to 25% of the shares subject thereto on January 1, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F2	Reflects a 8.4-for-1 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement.

Content

The Option vests with respect to 25% of the shares subject thereto on January 1, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Reflects a 8.4-for-1 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement.